凉血活血汤对脓毒症急性肾损伤小鼠肠道菌群及NLRP3/caspase-1/GSDMD信号通路的影响
研究采用盲肠结扎穿孔(CLP)建立脓毒症急性肾损伤小鼠模型,30只雄性C57BL/6小鼠随机分为假手术组、脓毒症组和脓毒症+凉血活血汤组,每组10只。凉血活血汤组在造模前2小时以6 g/kg灌胃给药,24小时后处死取材。结果显示,凉血活血汤可显著降低肾和结肠病理评分、降低肾组织IL-1β和IL-18 mRNA表达及NLRP3、caspase-1、GSDMD蛋白表达,并改善肠道菌群组成。结论提示凉血活血汤对脓毒症诱导的急性肾损伤有明显保护作用,可能通过调节肠道菌群改善肠道屏障,进而抑制肾组织NLRP3/caspase-1/GSDMD信号通路活化。
要点
- 在CLP脓毒症AKI小鼠中,凉血活血汤6 g/kg于造模前2小时灌胃,肾病理评分1.75±0.43 vs 3.50±0.50、结肠1.25±0.43 vs 4.50±0.50,均P<0.05。
- 凉血活血汤降低肾组织IL-1β mRNA(2-ΔΔCt)1.59±0.05 vs 4.61±0.88、IL-18 mRNA 1.69±0.17 vs 2.86±0.63,均P<0.05。
- 凉血活血汤降低肾组织NLRP3/GAPDH 0.71±0.04 vs 0.89±0.01、caspase-1/GAPDH 1.04±0.04 vs 1.48±0.04、GSDMD/GAPDH 0.90±0.01 vs 1.41±0.02,均P<0.05。
- CLP组肠道菌群物种丰富度显著下降,肠球菌属和埃希菌-志贺菌属相对丰度显著增加;凉血活血汤降低两者丰度并提高乳杆菌属和Akkermansia相对丰度。
- 该研究为小鼠动物实验,结果不能直接转化为临床推荐。
适用人群与场景
- 雄性C57BL/6小鼠,采用盲肠结扎穿孔(CLP)建立脓毒症急性肾损伤模型;假手术组仅行剖腹术。
处置流程与药物剂量
- 凉血活血汤组于造模前2小时以6 g/kg剂量灌胃给药;假手术组和脓毒症组给予等体积生理盐水灌胃。
- 造模24小时后麻醉处死小鼠,取结肠、肾组织及结肠内新鲜粪便。
研究设计与关键结果
- 研究类型为动物实验,30只雄性C57BL/6小鼠随机分为假手术组、脓毒症组和脓毒症+凉血活血汤组,每组10只。
- 与假手术组比较,脓毒症组肾组织炎性细胞浸润增加、肾空泡化,肾组织IL-1β、IL-18 mRNA及NLRP3、caspase-1、GSDMD蛋白表达显著增加;肠道菌群物种丰富度显著下降,肠球菌属和埃希菌-志贺菌属相对丰度显著增加,Ileibacterium、Alloprevotella、毛螺菌科、克雷伯菌属和Parasutterella相对丰度显著增加。
- 与脓毒症组比较,凉血活血汤显著减轻肾和结肠组织病理改变,病理评分肾组织1.75±0.43 vs 3.50±0.50、结肠组织1.25±0.43 vs 4.50±0.50,均P<0.05。
- 与脓毒症组比较,凉血活血汤改善肠道菌群组成,降低肠球菌属和埃希菌-志贺菌属相对丰度,显著增加乳杆菌属和Akkermansia相对丰度。
- 与脓毒症组比较,凉血活血汤显著降低肾组织IL-1β mRNA(2-ΔΔCt)1.59±0.05 vs 4.61±0.88、IL-18 mRNA(2-ΔΔCt)1.69±0.17 vs 2.86±0.63,均P<0.05。
- 与脓毒症组比较,凉血活血汤显著降低肾组织NLRP3/GAPDH 0.71±0.04 vs 0.89±0.01、caspase-1/GAPDH 1.04±0.04 vs 1.48±0.04、GSDMD/GAPDH 0.90±0.01 vs 1.41±0.02,均P<0.05。
证据类型、等级与局限
- 证据类型:动物实验(小鼠CLP模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究为小鼠实验,结果不能直接转化为急诊或ICU临床推荐;凉血活血汤6 g/kg灌胃为动物实验方案剂量,非临床推荐剂量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the effect of Liangxue Huoxue decoction on intestinal flora, intestinal barrier and NOD-like receptor protein 3 (NLRP3)/caspase-1/gasdermin D (GSDMD) pyroptosis signaling pathway in mice model of sepsis-induced acute kidney injury (AKI).
METHODS: The model of AKI was established by cecal ligation and perforation (CLP). Thirty male C57BL/6 mice were randomly divided into sham operation group (Sham group), sepsis group (CLP group) and sepsis+Liangxue Huoxue decoction (CLP+LXHX group), with 10 mice in each group. Mice in Sham group only underwent laparotomy. Two hours before model establishment, mice in CLP+LXHX group were treated with Liangxue Huoxue decoction (6 g/kg) by gavage; mice in Sham group and CLP group were given equal volume of normal saline by gavages. After 24 hours of modeling, all mice were sacrificed under anesthesia, and the colon and kidney tissues and fresh feces in the colon were taken. The pathological changes of kidney and colon were observed by hematoxylin-eosin (HE) staining under light microscope. Real-time polymerase chain reaction (RT-PCR) was used to detect inflammatory factors (interleukins, IL-1β and IL-18) in renal tissue. The expressions of NLRP3, caspase-1 and GSDMD were detected by Western blotting. The changes of intestinal flora in mice were detected by 16S rDNA high-throughput sequencing.
RESULTS: Compared with the Sham group, the inflammatory cell infiltration of the kidney tissue was increased and the kidney became vacuolated in CLP group, the mRNA expressions of IL-1β, IL-18, and the protein expressions of NLRP3, caspase-1 and GSDMD were significantly increased in CLP group, the species richness of intestinal microflora decreased significantly, the relative abundance of Enterococcus and Escherichia-Shigella increased significantly, and the relative abundance of Ileibacterium, Alloprevotella, Lachnospiraceae, Klebsiella and Parasutterella increased significantly in CLP group. Compared with CLP group, Liangxue Huoxue decoction can significantly reduce the pathological changes of kidney and colon tissue, reduce the pathological score (1.75±0.43 vs. 3.50±0.50 for kidney tissue, 1.25±0.43 vs. 4.50±0.50 for colon tissue, both P < 0.05), improve the composition of intestinal flora, reduce the relative abundance of Enterococcus and Escherichia-Shigella, and significantly increase the relative abundance of Lactobacillus and Akkermansia. In addition, Liangxue Huoxue decoction can significantly reduce mRNA expressions of IL-1β and IL-18 in kidney tissue [IL-1β mRNA (2-ΔΔCt): 1.59±0.05 vs. 4.61±0.88, IL-18 mRNA (2-ΔΔCt): 1.69±0.17 vs. 2.86±0.63, both P < 0.05] and the protein expressions of NLRP3, caspase-1 and GSDMD (NLRP3/GAPDH: 0.71±0.04 vs. 0.89±0.01, caspase-1/GAPDH: 1.04±0.04 vs. 1.48±0.04, GSDMD/GAPDH: 0.90±0.01 vs. 1.41±0.02, all P < 0.05).
CONCLUSIONS: Liangxue Huoxue decoction has obvious protective effect on AKI induced by sepsis. It can improve intestinal barrier by regulating intestinal flora, thereby inhibiting the activation of NLRP3/caspase-1/GSDMD signaling pathway in kidney tissue and reducing the expression of proptosis-related inflammatory factors.
参考来源
- Zhou M, Yang L, Zhuo Y, et al. [Effect of Liangxue Huoxue decoction on intestinal flora and NLRP3/caspase-1/GSDMD signaling pathway in mice model of sepsis-induced acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36916336. doi:10.3760/cma.j.cn121430-20221122-01018
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。